(Q40669960)

22 September 2017

A residue in the S2 subsite controls substrate selectivity of matrix metalloproteinase-2 and matrix metalloproteinase-9. (English)

1 reference

22 September 2017

2

1 reference

22 September 2017

3

1 reference

22 September 2017

Emily I Chen

1

1 reference

22 September 2017

Eric W Howard

series ordinal

4

1 reference

22 September 2017

Jeffrey W Smith

series ordinal

5

1 reference

22 September 2017

language of work or name

English

0 references

publication date

18 February 2003

1 reference

Journal of Biological Chemistry

22 September 2017

1 reference

22 September 2017

278

1 reference

22 September 2017

19

1 reference

22 September 2017

17158-17163

1 reference

How matrix metalloproteinases regulate cell behavior

22 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

Tumor targeting with a selective gelatinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

Development of matrix metalloproteinase inhibitors in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

Matrix metalloproteinases: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

The metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

Matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

A unique substrate recognition profile for matrix metalloproteinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

Origins of the specificity of tissue-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

Substrate hydrolysis by matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

Phase I/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210324200

21 January 2018

Identifiers

DOI

10.1074/JBC.M210324200

1 reference

22 September 2017

1 reference